Abstract
Molecular genetic studies of the effects of rare, pathogenic mutations have provided deep insights into mechanisms of causation for all forms of autism spectrum disorder (ASD) and highlight a new opportunity to specify treatment, prognosis, family recurrence risk, and the prospective management of common “comorbidities” that exacerbate the severity of impairment in ASD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have